Entering text into the input field will update the search result below

Danaher to sell certain businesses to Sartorius for $750M

  • Danaher (NYSE:DHR) has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to Sartorius AG (OTC:SARTF) for ~$750M.
  • The agreement was signed as a step towards obtaining regulatory approval for its pending acquisition of the GE Biopharma business.
  • The transaction is expected to be closed in Q1 2020.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
DHR
--
SARTF
--